oxidopamine has been researched along with Hemorrhagic Shock in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Excerpt | Relevance | Reference |
---|---|---|
"The early stress responses to hemorrhagic shock, trauma and endotoxicosis are associated with an early proinflammatory response characterized by increased gene expression of proinflammatory cytokines, PMN influx and accumulation in the lung and apoptosis." | 1.31 | Noradrenergic inhibition of TNF upregulation in hemorrhagic shock. ( Molina, PE, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Molina, PE | 1 |
1 other study available for oxidopamine and Hemorrhagic Shock
Article | Year |
---|---|
Noradrenergic inhibition of TNF upregulation in hemorrhagic shock.
Topics: Animals; Apoptosis; beta-Endorphin; Catecholamines; Corticosterone; Hypotension; Lung; Male; Neuroim | 2001 |